JW
Julie Winkler
Sr MD Chief Commercial Officer

Julie Winkler insider trades: Cme Group (CME) stock sales

Sr MD Chief Commercial Officer, Cme Group Last trade Nov 2, 2026 33 Form 4 filings
$3.1M
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2017
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Julie reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 2, 2026CME↓ Sell$3.1M
Feb 13, 2025CME↓ Sell$2.9M
Aug 10, 2023CME↓ Sell$1.3M
May 27, 2021CME↓ Sell$760K
Dec 14, 2020CME↓ Sell$735K
Feb 24, 2020CME↓ Sell$1.2M
Jun 12, 2019CME↓ Sell$944K
Nov 16, 2018CME↓ Sell$1.1M
Dec 7, 2017CME↓ Sell$370K
Jun 12, 2017CME↓ Sell$539K
Feb 24, 2017CME↓ Sell$721K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CME insiders

Open-market trades in the last 12 months

About Julie Winkler's insider trades

Julie Winkler is Sr MD Chief Commercial Officer at Cme Group (CME). Since Feb 24, 2017, Julie has reported no open-market purchases and 11 sales worth $13.7M on SEC Form 4. In the last 12 months: 1 sale ($3.1M).

Their filings also include shares withheld for taxes (22 filings), grants and awards (19 filings), option exercises (5 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CME insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.